NATCO Pharma Limited (NSE:NATCOPHARM)
861.75
+2.80 (0.33%)
Jun 5, 2025, 3:30 PM IST
NATCO Pharma Revenue
In the fiscal year ending March 31, 2025, NATCO Pharma had annual revenue of 44.30B INR with 10.68% growth. NATCO Pharma had revenue of 12.21B in the quarter ending March 31, 2025, with 13.95% growth.
Revenue
44.30B
Revenue Growth
+10.68%
P/S Ratio
3.48
Revenue / Employee
11.03M
Employees
4,016
Market Cap
154.35B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Mar 31, 2025 | 44.30B | 4.28B | 10.68% |
Mar 31, 2024 | 40.02B | 12.94B | 47.76% |
Mar 31, 2023 | 27.09B | 7.62B | 39.17% |
Mar 31, 2022 | 19.46B | -1.10B | -5.35% |
Mar 31, 2021 | 20.56B | 1.41B | 7.37% |
Mar 31, 2020 | Pro | Pro | Pro |
Mar 31, 2019 | Pro | Pro | Pro |
Mar 31, 2018 | Pro | Pro | Pro |
Mar 31, 2017 | Pro | Pro | Pro |
Mar 31, 2016 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Sun Pharmaceutical Industries | 525.78B |
Divi's Laboratories | 93.60B |
Cipla | 271.45B |
Apollo Hospitals Enterprise | 217.94B |
Mankind Pharma | 122.07B |
Zydus Lifesciences | 232.42B |
Aurobindo Pharma | 317.24B |
Alkem Laboratories | 129.65B |
NATCO Pharma News
- 7 days ago - Natco Pharma shares jump 4% as Q4 revenue jumps 14.3% YoY to Rs 1,221 crore - Business Upturn
- 8 days ago - Q4 earnings results today: IRCTC, Deepak Nitrite, Natco Pharma, SAIL, Cummins, Welspun Corp among key companies to report - Business Upturn
- 2 months ago - NATCO Pharma plans to launch generic Risdiplam in India, awaiting court clearance - Business Upturn
- 2 months ago - Natco Pharma shares fall 5% today as Trump warns of aggressive pharma tariffs - Business Upturn
- 2 months ago - Natco Pharma shares rally over 5% as U.S. exempts Indian generics from tariff blow - Business Upturn
- 3 months ago - Stocks hitting 52-week low today, February 20: Natco Pharma, VIP Industries, Birlasoft and more - Business Upturn
- 3 months ago - Stocks hitting 52-week low today, February 19: Natco Pharma, Godrej Consumer, Trident, BEML and more - Business Upturn
- 3 months ago - Natco Pharma Ltd (BOM:524816) Q3 2025 Earnings Call Highlights: Navigating Challenges with ... - GuruFocus